Context Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTX and other ETFs, options, and stocks.

About CNTX

Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.

CEO

Martin A. Lehr

CEOMartin A. Lehr

Employees

Employees12

Headquarters

Philadelphia, Pennsylvania

HeadquartersPhiladelphia, Pennsylvania

Founded

2015

Founded2015

Employees

Employees12

CNTX Key Statistics

Market cap

52.20M

Market cap52.20M

Price-Earnings ratio

-1.80

Price-Earnings ratio-1.80

Dividend yield

—

Dividend yield—

Average volume

160.75K

Average volume160.75K

High today

$0.6499

High today$0.6499

Low today

$0.49

Low today$0.49

Open price

$0.6172

Open price$0.6172

Volume

1.04M

Volume1.04M

52 Week high

$2.75

52 Week high$2.75

52 Week low

$0.49

52 Week low$0.49

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own CNTX. This list is generated using Robinhood data, and it’s not a recommendation.